Cowen & Co
http://www.cowen.com/default.htmlCowen and Company offers investment banking services, including equity research, equity and convertible debt financings, mergers and acquisitions advisory services, and restricted security sales.
-
Intercept Pharmaceuticals (ICPT) Answers Some Questions, Raises Others - Cowen
-
Intercept to Present at Upcoming Investor Conferences
-
Intercept Pharmaceuticals (ICPT) PT Raised to $149 at Cowen
-
Intercept Pharmaceuticals (ICPT) PT Raised to $120 at Cowen
-
Intercept Pharmaceuticals (ICPT) PT Lowered to $88 at Cowen
-
Intercept Pharmaceuticals (ICPT) PT Lowered to $99 at Cowen
-
Intercept to Report 2017 Full Year Financial Results on February 14 and Present at Upcoming Conferences
-
Cowen Cuts Ocaliva Estimate, Remains Outperform Rated on Intercept Pharma (ICPT)
-
Pre-Open Movers 09/22: (ASND) (SVRA) (S) Higher; (VSAR) (ICPT) (FINL) Lower (more...)
-
Intercept Pharma (ICPT): Updated Box And Warning Likely, PT Drops To $112 - Cowen
-
Intercept to Report 2016 Full Year Financial Results on February 23 and Present at Upcoming Conferences
-
Notable Analyst Rating Changes 3/30: (AAPL) (SHAK) (AIG) Upgraded; (INOV) (CMP) (SWN) Downgraded
-
Intercept Pharma (ICPT) Gains After-Hours
-
Intercept to Report 2015 Full Year Financial Results on February 23 and Present at Upcoming Conference
-
Streetinsider.com's Hot Lunchtime Reads 12/16: (FCEL) (V) (ICPT) (VRX) (MBLY)
-
Intercept (ICPT) Waiting for Catalysts - Cowen
-
Notable Analyst Rating Changes 8/13: (MSFT) (YHOO) (EZCH) Upgraded; (BABA) (ATW) (TMK) Downgraded
-
Cowen Reiterates Bullish View on Intercept Pharmaceuticals (ICPT) Ahead of Catalysts, Trims PT to $412
-
Fresh Off Generic Sale, Allergan (AGN) is Poised for Merger of Epic Proportions (AMGN) (ABBV)
-
Streetinsider.com's Hot Lunchtime Reads 12/18: (CHH) (DE) (NQ) (BBRY)
-
Notable Analyst Rating Changes 9/5: (IPCI) (CIEN) (BP) Upgraded; (TTWO) (PCLN) (MS) Downgraded
-
UPDATE: Cowen Starts Intercept Pharmaceuticals (ICPT) at Outperform
-
Notable Analyst Rating Changes 07/01: (NFLX) (FOLD) (NBR) Upgraded; (GS) (MNKD) (URBN) Downgraded
-
Notable Analyst Rating Changes 05/15: (PLUG) (PTX) (TWTR) Upgraded; (BMY) (HII) (CXP) Downgraded
-
Intercept Pharmaceuticals Appoints Rachel McMinn, Ph.D. as Chief Strategy Officer
-
Pre-Open Stock Movers 3/14: (HART) (MEET) (LMCA) Higher; (ARO) (ZBB) (PLUG) Lower (more...)